financetom
Business
financetom
/
Business
/
BHP's Acquisition Deadline Approaches As Anglo's $9B Project Faces Uncertainty
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BHP's Acquisition Deadline Approaches As Anglo's $9B Project Faces Uncertainty
May 20, 2024 6:30 AM

BHP Group ( BHP )‘s pursuit of Anglo American has become increasingly complex as a May 22 deadline approaches. BHP’s initial $43 billion offer to acquire its rival has been rejected twice, prompting BHP to weigh a revised proposal. However, BHP hesitates to move forward without some sign of reciprocation from Anglo, at a pivotal time for the industry since copper and gold just hit fresh all-time highs.

Despite the rejection, BHP's shares have been ticking higher, driven by surging commodity prices. This situation has buoyed investor confidence, even as the potential acquisition hangs in the balance. Shareholders from both companies are bracing for a final bid, though a hostile takeover seems unlikely.

Faced with BHP's advances, Anglo American has announced a faster-than-anticipated restructuring plan, including divesting its platinum, diamonds, and coal assets while accelerating its focus on copper.

Its largest shareholders, BlackRock and South Africa's Public Investment Corporation have remained silent, and their positions are potentially critical. Meanwhile, Elliott Investment Management‘s involvement further complicates the scenario.

Now read: Zijin Mining Sets Ambitious 50% Growth Target For Copper Production By 2028

The possible takeover has jeopardized some of Anglo American's large projects, particularly the $9 billion Woodsmith fertilizer mine in northern England. Workers at Woodsmith are particularly concerned, given that BHP is simultaneously investing in a $10 billion fertilizer facility in Canada. This parallel development raises questions about the viability of the Yorkshire project if BHP's acquisition succeeds.

"There's a lot of local jobs, young people starting apprenticeships. We were told these would be secure jobs for 100 years," Robert Goodwill, the local Conservative member of parliament, told Bloomberg.

The mine is located in the North Yorkshire region, an area already struggling with high unemployment. Anglo's recent decision to reduce capital expenditure on the mine has only heightened these concerns. The mine was expected to provide 2,000 jobs and boost the local economy, but its future now seems uncertain.

Also read: Thieves Are Stealing Copper Cables From Tesla Charging Stations Amid Sky-High Prices For Vital Metal

Benzinga Mining is the bridge between mining companies and retail investors. Reach out to [email protected] to get started!

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Immunocore Converts Skin Cancer Therapy Phase 2/3 Trial to Phase 3
Immunocore Converts Skin Cancer Therapy Phase 2/3 Trial to Phase 3
May 29, 2024
08:14 AM EDT, 05/29/2024 (MT Newswires) -- Immunocore Holdings ( IMCR ) said Wednesday a phase 2/3 trial evaluating its therapy candidate, Kimmtrak as a monotherapy and in combination with pembrolizumab to treat certain patients with skin cancer has been converted into a phase 3 trial. The decision comes following a consultation with the US Food and Drug Administration, the...
Milestone Pharmaceuticals Says US FDA Accepts New Drug Application for Cardamyst Nasal Spray for Arrhythmia
Milestone Pharmaceuticals Says US FDA Accepts New Drug Application for Cardamyst Nasal Spray for Arrhythmia
May 29, 2024
08:10 AM EDT, 05/29/2024 (MT Newswires) -- Milestone Pharmaceuticals ( MIST ) said Wednesday that the US Food and Drug Administration has accepted its New Drug Application for Cardamyst nasal spray for the management of paroxysmal supraventricular tachycardia, or PSVT, a type of arrhythmia or abnormal heart rhythm. The company said the regulator's Prescription Drug User Fee Act target date...
TScan Therapeutics' Potential Blood Cancer Therapies Receive FDA Regenerative Medicine Status
TScan Therapeutics' Potential Blood Cancer Therapies Receive FDA Regenerative Medicine Status
May 29, 2024
08:15 AM EDT, 05/29/2024 (MT Newswires) -- TScan Therapeutics ( TCRX ) said Wednesday it has received the US Food and Drug Administration's Regenerative Medicine Advanced Therapy designation for its blood malignancy treatment candidates TSC-100 and TSC-101. The company said TSC-100 and TSC-101 are the lead therapy candidates in its heme malignancies program aimed at treating patients with acute myeloid...
Redwire Forms Coalition to Support Research Projects, AI in Space Operations
Redwire Forms Coalition to Support Research Projects, AI in Space Operations
May 29, 2024
08:14 AM EDT, 05/29/2024 (MT Newswires) -- Redwire ( RDW ) said Wednesday it has formed a coalition that will fund research projects focusing on using artificial intelligence in space operations. Redwire ( RDW ) is one of the two corporate sponsors of the Center for AEroSpace Autonomy Research, or CAESAR, at Stanford University, which aims to leverage various disciplines...
Copyright 2023-2026 - www.financetom.com All Rights Reserved